Potential diagnostic consequences of applying non-invasive prenatal testing: Population-based study from a country with existing first-trimester screening

Ultrasound in Obstetrics and Gynecology

Volumn 43, Issue 3, 2014, Pages 265-271

  Petersen, O B ^a   Vogel, I ^a   Ekelund, C ^b   Hyett, J ^c   Tabor, A ^b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b Rigshospitalet   (Denmark)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

chromosomal anomaly; free fetal DNA; NIPT; prenatal diagnosis; prenatal screening

Indexed keywords

BIOLOGICAL MARKER; CHORIONIC GONADOTROPIN BETA SUBUNIT; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADULT; BLOOD; CHROMOSOME DISORDERS; DENMARK; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; MATERNAL AGE; METABOLISM; NEWBORN; NUCHAL TRANSLUCENCY MEASUREMENT; PRACTICE GUIDELINE; PREGNANCY; PRENATAL DIAGNOSIS; PROCEDURES; RETROSPECTIVE STUDY; RISK FACTOR; STANDARDS;

ADULT; BIOLOGICAL MARKERS; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; CHROMOSOME DISORDERS; DENMARK; FEMALE; HUMANS; INFANT, NEWBORN; MATERNAL AGE; NUCHAL TRANSLUCENCY MEASUREMENT; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PRENATAL DIAGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84897599061     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.13270     Document Type: Article

References (24)

1. Palomaki GE, Kloza EM, Lambert-Messerlian GM, Haddow JE, Neveux LM, Ehrich M, van den Boom D, Bombard AT, Deciu C, Grody WW, Nelson SF, Canick JA,. DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet Med 2011; 13: 913-920.
2. Ashoor G, Syngelaki A, Wagner M, Birdir C, Nicolaides KH,. Chromosome-selective sequencing of maternal plasma cell-free DNA for first-trimester detection of trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012; 206: 322.e1-5.
3. Bianchi DW, Platt LD, Goldberg JD, Abuhamad AZ, Sehnert AJ, Rava RP,; MatErnal BLood IS Source to Accurately diagnose fetal aneuploidy (MELISSA) Study Group. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol 2012; 119: 890-901. Erratum in Obstet Gynecol 2012; 120: 957.
4. Dan S, Wang W, Ren J, Li Y, Hu H, Xu Z, Lau TK, Xie J, Zhao W, Huang H, Xie J, Sun L, Zhang X, Wang W, Liao S, Qiang R, Cao J, Zhang Q, Zhou Y, Zhu H, Zhong M, Guo Y, Lin L, Gao Z, Yao H, Zhang H, Zhao L, Jiang F, Chen F, Jiang H, Li S, Li Y, Wang J, Wang J, Duan T, Su Y, Zhang X,. Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11,105 pregnancies with mixed risk factors. Prenat Diagn 2012; 32: 1225-1232.
5. Zimmermann B, Hill M, Gemelos G, Demko Z, Banjevic M, Baner J, Ryan A, Sigurjonsson S, Chopra N, Dodd M, Levy B, Rabinowitz M,. Noninvasive prenatal aneuploidy testing of chromosomes 13, 18, 21, X, and Y, using targeted sequencing of polymorphic loci. Prenat Diagn 2012; 32: 1233-1241.
6. Lo YM, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW, Wainscoat JS,. Presence of fetal DNA in maternal plasma and serum. Lancet 1997; 350: 485-487.
7. Hyland CA, Gardener GJ, Davies H, Ahvenainen M, Flower RL, Irwin D, Morris JM, Ward CM, Hyett JA,. Evaluation of non-invasive prenatal RHD genotyping of the fetus. Med J Aust 2009; 191: 21-25.
8. Patsalis PC, Tsaliki E, Koumbaris G, Karagrigoriou A, Velissariou V, Papageorgiou EA,. A new non-invasive prenatal diagnosis of Down syndrome through epigenetic markers and real-time qPCR. Expert Opin Biol Ther 2012; 12 (Suppl 1): S155-S161.
9. Srinivasan A, Bianchi DW, Huang H, Sehnert AJ, Rava RP,. Noninvasive detection of fetal subchromosome abnormalities via deep sequencing of maternal plasma. Am J Hum Genet 2013; 92: 167-176.
10. Stein Z, Susser M, Guterman AV,. Screening programme for prevention of Down's syndrome. Lancet 1973; 1: 305-310.
11. Cuckle HS, Wald NJ, Barkai G, Fuhrmann W, Altland K, Brambati B, Knight G, Palomaki G, Haddow JE, Canick J,. First-trimester biochemical screening for Down syndrome. Lancet 1988; 2: 851-852.
12. Kagan KO, Etchegaray A, Zhou Y, Wright D, Nicolaides KH,. Prospective validation of first-trimester combined screening for trisomy 21. Ultrasound Obstet Gynecol 2009; 34: 14-18.
13. Syngelaki A, Chelemen T, Dagklis T, Allan L, Nicolaides KH,. Challenges in the diagnosis of fetal non-chromosomal abnormalities at 11-13 weeks. Prenat Diagn 2011; 31: 90-102.
14. Poon LC, Syngelaki A, Akolekar R, Lai J, Nicolaides KH,. Combined screening for preeclampsia and small for gestational age at 11-13 weeks. Fetal Diagn Ther 2013; 33: 16-27.
15. Wapner RJ, Martin CL, Levy B, Ballif BC, Eng CM, Zachary JM, Savage M, Platt LD, Saltzman D, Grobman WA, Klugman S, Scholl T, Simpson JL, McCall K, Aggarwal VS, Bunke B, Nahum O, Patel A, Lamb AN, Thom EA, Beaudet AL, Ledbetter DH, Shaffer LG, Jackson L,. Chromosomal microarray versus karyotyping for prenatal diagnosis. N Engl J Med 2012; 367: 2175-2184.
16. Shaffer LG, Dabell MP, Fisher AJ, Coppinger J, Bandholz AM, Ellison JW, Ravnan JB, Torchia BS, Ballif BC, Rosenfeld JA,. Experience with microarray-based comparative genomic hybridization for prenatal diagnosis in over 5000 pregnancies. Prenat Diagn 2012; 32: 976-985.
17. American College of Obstetricians and Gynecologists Committee on Genetics. Committee Opinion No. 545: Noninvasive prenatal testing for fetal aneuploidy. Obstet Gynecol 2012; 120: 1532-1534.
18. Nicolaides KH, Syngelaki A, Ashoor G, Birdir C, Touzet G,. Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population. Am J Obstet Gynecol 2012; 207: 374.e1-6.
19. Ekelund CK, Jørgensen FS, Petersen OB, Sundberg K, Tabor A,; Danish Fetal Medicine Research Group. Impact of a new national screening policy for Down's syndrome in Denmark: population based cohort study. BMJ 2008; 337: a2547.
20. Benkhalifa M, Janny L, Vye P, Malet P, Boucher D, Menezo Y,. Assessment of polyploidy in human morulae and blastocysts using co-culture and fluorescent in-situ hybridization. Hum Reprod 1993; 8: 895-902.
21. Caine A, Maltby AE, Parkin CA, Waters JJ, Crolla JA,; UK Association of Clinical Cytogeneticists (ACC). Prenatal detection of Down's syndrome by rapid aneuploidy testing for chromosomes 13, 18, and 21 by FISH or PCR without a full karyotype: a cytogenetic risk assessment. Lancet 2005; 366: 123-128.
22. Midro AT, Stengel-Rutkowski S, Stene J,. Experiences with risk estimates for carriers of chromosomal reciprocal translocations. Clin Genet 1992; 41: 113-122.
23. Evans MI, Henry GP, Miller WA, Bui TH, Snidjers RJ, Wapner RJ, Miny P, Johnson MP, Peakman D, Johnson A, Nicolaides K, Holzgreve W, Ebrahim SA, Babu R, Jackson L,. International, collaborative assessment of 146,000 prenatal karyotypes: expected limitations if only chromosome-specific probes and fluorescent in-situ hybridization are used. Hum Reprod 1999; 14: 1213-1216.
24. Chitty LS, Kagan KO, Molina FS, Waters JJ, Nicolaides KH,. Fetal nuchal translucency scan and early prenatal diagnosis of chromosomal abnormalities by rapid aneuploidy screening: observational study. BMJ 2006; 332: 452-455.